Vidas Proesterone (PRG) (30 409)

FDA 510(k) K965084 · bioMerieux, Inc.

Substantially Equivalent

510(k) numberK965084

Submission

Device name
Vidas Proesterone (PRG) (30 409)
Applicant
bioMerieux, Inc.
Rockland, MA, US
Received
December 19, 1996
Decision date
January 9, 1997
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
JLS – Radioimmunoassay, Progesterone
Device class
Class I (low risk)
Regulation
21 CFR 862.1620
Specialty
Clinical Chemistry

Other 510(k)s with product code JLS

510(k)DeviceApplicantDecision
K040923Luminescent Immunoassay Kit for the Detection of Progesterone in SalivaJLS · Traditional Ibl GmbH07/22/2004SE
K973898Progesterone ElisaJLS · Traditional Kmi Diagnostics, Inc.11/13/1997SE
K972133Vitros Immunodiagnostics Products Progesterone Reagent Pack (GEM.1070), Progesterone…JLS · Traditional Johnson & Johnson Clinical Diagnostics, Inc.06/24/1997SE
K971725Opus ProgesteroneJLS · Traditional Behring Diagnostics, Inc.06/18/1997SE
K964841Elecsys Progesterone AssayJLS · Traditional Boehringer Mannheim Corp.03/24/1997SE
K955025Axsym ProgesteroneJLS · Traditional Abbott Laboratories03/07/1996SE
K955769Access Progesterone AssayJLS · Traditional Bio-Rad Laboratories, Inc.02/05/1996SE
K952075Progesterone Assay for the Technicon Immuno 1 System In-Bitro Diagnostic SystemJLS · Traditional Bayer Corp.06/13/1995SE
K951630Auraflex Progesterone 150TEST PackJLS · Traditional Organon Teknika Corp.05/08/1995SE
K950570Stratus Progesterone Fluorometric Enzyme ImmunoassayJLS · Traditional Baxter Diagnostics, Inc.04/11/1995SE

More from Baxter Diagnostics, Inc.

510(k)DeviceDecision
K260160VITEK REVEAL GN AST Assay and VITEK REVEAL AST SystemSAN · Traditional 07/08/2026SE
K260282VITEK 2 AST-Streptococcus Inducible Clindamycin ResistanceLON · Traditional 04/15/2026SE
K260281VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)LON · Traditional 03/26/2026SE
K251579VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)LON · Traditional 08/21/2025SE
K234012Vitek Compact ProLON · Traditional 03/14/2025SE
K232967VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)NGZ · Traditional 06/12/2024SE
K232963VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)NGZ · Traditional 06/07/2024SE
K240279Vidas Tbi (Gfap, UCH-L1)QAT · Traditional 05/01/2024SE
K234000VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL)LON · Traditional 03/11/2024SE
K232201VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus…LON · Traditional 10/23/2023SE

Questions and answers

When was Vidas Proesterone (PRG) (30 409) cleared by the FDA?

Vidas Proesterone (PRG) (30 409) (K965084) received a 510(k) decision of Substantially Equivalent on January 9, 1997, 21 days after the submission was received.

What is the product code of K965084?

The FDA product code is JLS – Radioimmunoassay, Progesterone, a Class I (low risk) device regulated under 21 CFR 862.1620.